Financials Apiam Animal Health Limited

Equities

AHX

AU000000AHX0

Healthcare Facilities & Services

Delayed Australian S.E. 09:14:25 2024-04-28 pm EDT 5-day change 1st Jan Change
0.4 AUD 0.00% Intraday chart for Apiam Animal Health Limited +11.11% +37.93%

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 78.52 55.07 53.63 126.8 115.7 91.8
Enterprise Value (EV) 1 104.4 79.94 102.2 179.7 176.3 186.7
P/E ratio 23.4 x 17.3 x 12.6 x 23.1 x 20.4 x 39.8 x
Yield 2.13% 3.08% 4.35% 2.5% 2.34% -
Capitalization / Revenue 0.74 x 0.49 x 0.45 x 1 x 0.74 x 0.48 x
EV / Revenue 0.98 x 0.72 x 0.86 x 1.42 x 1.12 x 0.97 x
EV / EBITDA 12.1 x 8.67 x 9.24 x 15.4 x 12.6 x 15.2 x
EV / FCF 24 x 34.1 x 12.6 x 40.8 x 15.4 x 21.1 x
FCF Yield 4.16% 2.93% 7.93% 2.45% 6.51% 4.74%
Price to Book 1.35 x 0.91 x 0.79 x 1.61 x 1.1 x 0.78 x
Nbr of stocks (in thousands) 104,694 105,898 116,597 132,055 168,928 180,005
Reference price 2 0.7500 0.5200 0.4600 0.9600 0.6850 0.5100
Announcement Date 8/26/18 8/25/19 8/23/20 8/29/21 8/28/22 8/27/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 106.6 111.7 118.3 126.2 157.1 191.8
EBITDA 1 8.647 9.222 11.07 11.7 14.04 12.26
EBIT 1 6.215 6.064 7.766 8.277 9.584 6.569
Operating Margin 5.83% 5.43% 6.56% 6.56% 6.1% 3.43%
Earnings before Tax (EBT) 1 4.831 4.569 6.065 7.036 6.47 3.166
Net income 1 3.278 3.165 4.171 5.082 4.639 2.277
Net margin 3.08% 2.83% 3.52% 4.03% 2.95% 1.19%
EPS 2 0.0321 0.0301 0.0365 0.0416 0.0336 0.0128
Free Cash Flow 1 4.346 2.342 8.11 4.401 11.48 8.848
FCF margin 4.08% 2.1% 6.85% 3.49% 7.31% 4.61%
FCF Conversion (EBITDA) 50.26% 25.39% 73.27% 37.63% 81.77% 72.19%
FCF Conversion (Net income) 132.57% 73.98% 194.43% 86.6% 247.42% 388.58%
Dividend per Share 2 0.0160 0.0160 0.0200 0.0240 0.0160 -
Announcement Date 8/26/18 8/25/19 8/23/20 8/29/21 8/28/22 8/27/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2021 S1 2021 S2 2022 S1
Net sales - 65 -
EBITDA - 7.7 -
EBIT 4.4 4.4 -
Operating Margin - 6.77% -
Earnings before Tax (EBT) - - -
Net income 1 2.559 2.5 1.75
Net margin - 3.85% -
EPS 2 - 0.0216 0.000100
Dividend per Share - - -
Announcement Date 2/23/21 8/29/21 2/24/22
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 25.8 24.9 48.6 52.9 60.5 94.9
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.987 x 2.697 x 4.39 x 4.523 x 4.314 x 7.739 x
Free Cash Flow 1 4.35 2.34 8.11 4.4 11.5 8.85
ROE (net income / shareholders' equity) 5.81% 5.25% 6.61% 6.69% 4.79% 1.92%
ROA (Net income/ Total Assets) 3.87% 3.61% 3.95% 3.47% 3.36% 1.84%
Assets 1 84.64 87.62 105.5 146.5 138 123.5
Book Value Per Share 2 0.5500 0.5700 0.5800 0.6000 0.6200 0.6500
Cash Flow per Share 2 0.0100 0.0200 0.0200 0.0200 0.0200 0.0200
Capex 1 4.55 2.13 1.65 4.74 4.32 7.86
Capex / Sales 4.26% 1.9% 1.39% 3.75% 2.75% 4.1%
Announcement Date 8/26/18 8/25/19 8/23/20 8/29/21 8/28/22 8/27/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AHX Stock
  4. Financials Apiam Animal Health Limited